Investors in Hims & Hers Health are being reminded they can seek lead plaintiff status in a securities‑fraud class action tied to an FTC complaint, with a November 2 deadline
Executive summary: Rosen Law Firm notified investors that anyone who purchased Hims & Hers Health (NYSE: HIMS) securities between August 4 2025 and July 29 2026 may apply to serve as lead plaintiff in a securities‑fraud class action, with a filing deadline of November 2 2026. The choice of lead plaintiff influences how the litigation is conducted and can affect the size of any settlement or judgment, thereby impacting the company’s potential legal costs.
Who is involved: Hims & Hers Health, its executives, the Rosen Law Firm, and shareholders who bought HIMS shares during the class period.
Likely next (inference): Investors must submit lead‑plaintiff applications by November 2; the court will then select a lead plaintiff, after which the case will proceed toward discovery, settlement talks, or trial.
Rosen Law Firm’s notice covers anyone who bought HIMS shares between August 4 2025 and July 29 2026, inviting them to apply for lead‑plaintiff status before the November 2, 2026 deadline. The lawsuit stems from a federal complaint by the FTC alleging serious business misconduct by the company. The designation of a lead plaintiff will shape how the litigation proceeds and could affect any eventual settlement or judgment. No further details about the merits of the claims or potential damages are provided in the notice.
What's next — scenarios
Inference: scenarios and probabilities are Beyond's assessment, not reported fact.
Base: lead plaintiff appointed, case proceeds (50%)
Company faces legal expenses and a possible settlement in the tens of millions of dollars, affecting earnings.
- Court approves a lead plaintiff
- No dismissal motion is granted
Upside: case dismissed or settled for low cost (30%)
Limited financial impact; stock may recover as litigation risk recedes.
- Judge grants a motion to dismiss
- Settlement reached for less than $5 million
Downside: judgment against company with significant damages (20%)
Potential damages exceeding $100 million, creating a material adverse effect on financials and possibly triggering capital‑raising needs.
- Court finds liability after trial
- Judgment exceeds $50 million
What to watch
- November 2 2026 – deadline for lead‑plaintiff applications in the HIMS securities‑fraud class action
- Upcoming court hearing on lead‑plaintiff selection (timing to be set by the court)
- Any announcement of FTC enforcement action related to the underlying complaint
- Company’s quarterly earnings releases that may reveal accruals for legal expenses
Timeline
- — HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit (PR Newswire)
- — Hims & Hers Health (NYSE: HIMS) Faces Securities Fraud Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower (PR Newswire)
- — Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
Analysis — what this means
Likely next events
- November 2 2026 – deadline for lead‑plaintiff applications in the HIMS securities‑fraud class action
Sectors affected
- Online telehealth and direct‑to‑consumer prescription sector
Regulatory implications
- FTC may pursue enforcement under Section 5 of the FTC Act for alleged deceptive marketing, potentially resulting in injunctions and civil penalties.
Key entities
Sources
- HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit — PR Newswire
- Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — PR Newswire
- Hims & Hers Health (NYSE: HIMS) Faces Securities Fraud Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower — PR Newswire
Related cases
- ClaimsFiler reminds Hims & Hers investors with over $100k losses of the Nov 2 lead plaintiff deadline in an ongoing securities class action
- Hims & Hers Health faces intensifying legal scrutiny as class action lawsuits mount over alleged securities fraud
- Hims & Hers Health faces mounting legal pressure as investors prepare to lead a securities fraud class action lawsuit
- ClaimsFiler warns Hims & Hers investors with over $100k losses that the lead plaintiff deadline in the securities class action is November 2, 2026
- Hims & Hers Health faces a securities fraud class action covering trades from August 4, 2025 to July 29, 2026, with a lead plaintiff deadline of November 2, 2026
- Hims & Hers faces intensifying legal pressure as multiple law firms seek lead plaintiffs for securities fraud class actions